PNC Financial Services Group Inc. Sells 24,402 Shares of OraSure Technologies, Inc. (OSUR)

PNC Financial Services Group Inc. decreased its stake in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 52.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,186 shares of the medical instruments supplier’s stock after selling 24,402 shares during the quarter. PNC Financial Services Group Inc.’s holdings in OraSure Technologies were worth $383,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Alps Advisors Inc. raised its stake in shares of OraSure Technologies by 0.3% in the second quarter. Alps Advisors Inc. now owns 43,257 shares of the medical instruments supplier’s stock worth $747,000 after purchasing an additional 111 shares during the last quarter. Profund Advisors LLC raised its stake in shares of OraSure Technologies by 2.8% in the second quarter. Profund Advisors LLC now owns 10,903 shares of the medical instruments supplier’s stock worth $188,000 after purchasing an additional 293 shares during the last quarter. Timber Hill LLC raised its stake in shares of OraSure Technologies by 3.2% in the second quarter. Timber Hill LLC now owns 11,597 shares of the medical instruments supplier’s stock worth $200,000 after purchasing an additional 363 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of OraSure Technologies by 0.5% in the first quarter. Wellington Management Group LLP now owns 111,970 shares of the medical instruments supplier’s stock worth $1,448,000 after purchasing an additional 587 shares during the last quarter. Finally, Arizona State Retirement System raised its stake in shares of OraSure Technologies by 3.4% in the second quarter. Arizona State Retirement System now owns 30,100 shares of the medical instruments supplier’s stock worth $520,000 after purchasing an additional 1,000 shares during the last quarter. Institutional investors and hedge funds own 92.07% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://ledgergazette.com/2017/10/19/pnc-financial-services-group-inc-sells-24402-shares-of-orasure-technologies-inc-osur.html.

In other news, SVP Jack E. Jerrett sold 73,463 shares of the stock in a transaction on Monday, August 7th. The stock was sold at an average price of $20.77, for a total transaction of $1,525,826.51. Following the completion of the sale, the senior vice president now owns 81,593 shares in the company, valued at approximately $1,694,686.61. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Brian Smith sold 3,075 shares of the stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $21.09, for a total value of $64,851.75. Following the sale, the insider now owns 24,540 shares of the company’s stock, valued at approximately $517,548.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 717,601 shares of company stock valued at $14,977,398. Company insiders own 6.40% of the company’s stock.

OraSure Technologies, Inc. (OSUR) opened at 19.85 on Thursday. The stock has a market cap of $1.18 billion, a PE ratio of 36.69 and a beta of 1.55. The stock has a 50 day moving average price of $21.70 and a 200 day moving average price of $17.67. OraSure Technologies, Inc. has a 1-year low of $7.09 and a 1-year high of $23.01.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.09 EPS for the quarter, beating the consensus estimate of $0.07 by $0.02. OraSure Technologies had a return on equity of 15.64% and a net margin of 22.29%. The firm had revenue of $40.18 million during the quarter, compared to analyst estimates of $36.54 million. During the same quarter in the prior year, the business posted $0.07 EPS. The business’s revenue for the quarter was up 28.1% compared to the same quarter last year. On average, analysts predict that OraSure Technologies, Inc. will post $0.48 EPS for the current fiscal year.

OSUR has been the subject of several recent analyst reports. Stephens restated an “overweight” rating and issued a $19.00 price target (up previously from $14.00) on shares of OraSure Technologies in a research note on Tuesday, July 11th. BidaskClub cut OraSure Technologies from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Canaccord Genuity restated a “buy” rating and issued a $22.00 price target on shares of OraSure Technologies in a research note on Tuesday, September 19th.

Other large investors also recently made changes to their positions in the company. Alps Advisors Inc. raised its stake in shares of OraSure Technologies by 0.3% in the second quarter. Alps Advisors Inc. now owns 43,257 shares of the medical instruments supplier’s stock worth $747,000 after purchasing an additional 111 shares during the last quarter. Profund Advisors LLC raised its stake in shares of OraSure Technologies by 2.8% in the second quarter. Profund Advisors LLC now owns 10,903 shares of the medical instruments supplier’s stock worth $188,000 after purchasing an additional 293 shares during the last quarter. Timber Hill LLC raised its stake in shares of OraSure Technologies by 3.2% in the second quarter. Timber Hill LLC now owns 11,597 shares of the medical instruments supplier’s stock worth $200,000 after purchasing an additional 363 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of OraSure Technologies by 0.5% in the first quarter. Wellington Management Group LLP now owns 111,970 shares of the medical instruments supplier’s stock worth $1,448,000 after purchasing an additional 587 shares during the last quarter. Finally, Arizona State Retirement System raised its stake in shares of OraSure Technologies by 3.4% in the second quarter. Arizona State Retirement System now owns 30,100 shares of the medical instruments supplier’s stock worth $520,000 after purchasing an additional 1,000 shares during the last quarter. Institutional investors and hedge funds own 92.07% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://ledgergazette.com/2017/10/19/pnc-financial-services-group-inc-sells-24402-shares-of-orasure-technologies-inc-osur.html.

In other news, SVP Jack E. Jerrett sold 73,463 shares of the stock in a transaction on Monday, August 7th. The stock was sold at an average price of $20.77, for a total transaction of $1,525,826.51. Following the completion of the sale, the senior vice president now owns 81,593 shares in the company, valued at approximately $1,694,686.61. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Brian Smith sold 3,075 shares of the stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $21.09, for a total value of $64,851.75. Following the sale, the insider now owns 24,540 shares of the company’s stock, valued at approximately $517,548.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 717,601 shares of company stock valued at $14,977,398. Company insiders own 6.40% of the company’s stock.

OraSure Technologies, Inc. (OSUR) opened at 19.85 on Thursday. The stock has a market cap of $1.18 billion, a PE ratio of 36.69 and a beta of 1.55. The stock has a 50 day moving average price of $21.70 and a 200 day moving average price of $17.67. OraSure Technologies, Inc. has a 1-year low of $7.09 and a 1-year high of $23.01.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.09 EPS for the quarter, beating the consensus estimate of $0.07 by $0.02. OraSure Technologies had a return on equity of 15.64% and a net margin of 22.29%. The firm had revenue of $40.18 million during the quarter, compared to analyst estimates of $36.54 million. During the same quarter in the prior year, the business posted $0.07 EPS. The business’s revenue for the quarter was up 28.1% compared to the same quarter last year. On average, analysts predict that OraSure Technologies, Inc. will post $0.48 EPS for the current fiscal year.

OSUR has been the subject of several recent analyst reports. Stephens restated an “overweight” rating and issued a $19.00 price target (up previously from $14.00) on shares of OraSure Technologies in a research note on Tuesday, July 11th. BidaskClub cut OraSure Technologies from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Canaccord Genuity restated a “buy” rating and issued a $22.00 price target on shares of OraSure Technologies in a research note on Tuesday, September 19th. Zacks Investment Research upgraded OraSure Technologies from a “hold” rating to a “buy” rating and set a $24.00 price target for the company in a research note on Saturday, September 9th. Finally, Jefferies Group LLC boosted their price target on OraSure Technologies from $16.00 to $19.00 and gave the stock a “buy” rating in a research note on Wednesday, June 28th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $18.04.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.